Fingerprint
Dive into the research topics of 'Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically